What is CIBUS INC's earnings per share (EPS)?

CIBUS INC (CBUS) reported diluted earnings per share of $-2.78 for fiscal year 2025. This represents a 74.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CIBUS INC Financials

CBUS

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows CIBUS INC (CBUS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 20/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

CIBUS INC has an operating margin of -2680.1%, meaning the company retains $-2680 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -6062.8% the prior year.

Growth

CIBUS INC's revenue declined 14.6% year-over-year, from $4.3M to $3.6M. This contraction results in a growth score of 9/100.

Leverage

100

CIBUS INC carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

CIBUS INC's current ratio of 0.72 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 9/100, which could limit financial flexibility.

Cash Flow

While CIBUS INC generated -$50.6M in operating cash flow, capex of $578K consumed most of it, leaving -$51.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

CIBUS INC generates a -582.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -272.8% the prior year.

Piotroski F-Score Weak

3/9

CIBUS INC passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

0.40x

For every $1 of reported earnings, CIBUS INC generates $0.40 in operating cash flow (-$50.6M OCF vs -$127.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.6M

YoY-14.6%

5Y CAGR-31.3%

10Y CAGR+11.1%

CIBUS INC generated $3.6M in revenue in fiscal year 2025. This represents a decrease of 14.6% from the prior year.

EBITDA

-$91.6M

YoY+63.6%

CIBUS INC's EBITDA was -$91.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 63.6% from the prior year.

Net Income

-$127.1M

YoY+49.4%

CIBUS INC reported -$127.1M in net income in fiscal year 2025. This represents an increase of 49.4% from the prior year.

EPS (Diluted)

$-2.78

YoY+74.3%

CIBUS INC earned $-2.78 per diluted share (EPS) in fiscal year 2025. This represents an increase of 74.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$51.2M

YoY+13.1%

CIBUS INC generated -$51.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 13.1% from the prior year.

Cash & Debt

$9.9M

YoY-31.2%

5Y CAGR-10.5%

10Y CAGR-8.7%

CIBUS INC held $9.9M in cash against $93K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

-2680.1%

YoY+3382.7pp

5Y CAGR-2496.3pp

10Y CAGR-2223.0pp

CIBUS INC's operating margin was -2680.1% in fiscal year 2025, reflecting core business profitability. This is up 3382.7 percentage points from the prior year.

Net Margin

-3492.3%

YoY+2406.1pp

5Y CAGR-3304.3pp

10Y CAGR-3029.3pp

CIBUS INC's net profit margin was -3492.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2406.1 percentage points from the prior year.

Return on Equity

-582.2%

YoY-309.4pp

5Y CAGR-460.6pp

10Y CAGR-557.9pp

CIBUS INC's ROE was -582.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 309.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$44.2M

YoY-12.4%

5Y CAGR+31.9%

10Y CAGR+31.9%

CIBUS INC invested $44.2M in research and development in fiscal year 2025. This represents a decrease of 12.4% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$578K

YoY-28.5%

5Y CAGR-20.2%

10Y CAGR-1.4%

CIBUS INC invested $578K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 28.5% from the prior year.

CBUS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.6M-14.6%	$4.3M+134.6%	$1.8M+1057.3%	$157K-99.4%	$26.0M+9.0%	$23.9M
Cost of Revenue	N/A	N/A	N/A	$0-100.0%	$28.6M-18.7%	$35.1M
Gross Profit	N/A	N/A	N/A	$157K+106.1%	-$2.6M+77.2%	-$11.3M
R&D Expenses	$44.2M-12.4%	$50.4M+19.0%	$42.4M+266.7%	$11.6M+1.9%	$11.3M+2.3%	$11.1M
SG&A Expenses	$26.9M-12.6%	$30.8M+6.5%	$28.9M+163.5%	$11.0M	N/A	$16.2M
Operating Income	-$97.5M+62.3%	-$258.4M+19.0%	-$318.9M-1325.5%	-$22.4M+23.7%	-$29.3M+33.1%	-$43.8M
Interest Expense	N/A	N/A	N/A	$75K-94.8%	$1.4M-0.3%	$1.4M
Income Tax	$29K0.0%	$29K+825.0%	-$4K	$0	$0	$0
Net Income	-$127.1M+49.4%	-$251.4M+6.1%	-$267.6M-1484.4%	-$16.9M+42.2%	-$29.2M+34.9%	-$44.8M
EPS (Diluted)	$-2.78+74.3%	$-10.83+58.3%	$-25.95-41.3%	$-18.36-2253.8%	$-0.78+40.9%	$-1.32

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.1M+71.9%	$615K-34.1%	$933K-9.8%	$1.0M-14.7%	$1.2M-27.3%	$1.7M+98.9%	$838K+53.8%	$545K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$9.4M-13.0%	$10.8M-11.8%	$12.2M+3.6%	$11.8M-5.1%	$12.4M-4.3%	$13.0M0.0%	$13.0M+8.2%	$12.0M
SG&A Expenses	$5.1M-2.7%	$5.3M-20.8%	$6.7M-32.5%	$9.9M+44.9%	$6.8M-11.4%	$7.7M-17.6%	$9.3M+33.5%	$7.0M
Operating Income	-$22.6M-46.2%	-$15.4M+14.0%	-$17.9M+56.8%	-$41.6M-130.6%	-$18.0M+91.0%	-$200.4M-833.0%	-$21.5M-16.4%	-$18.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$6K+200.0%	-$6K-122.2%	$27K+1250.0%	$2K-66.7%	$6K-53.8%	$13K+425.0%	-$4K-128.6%	$14K
Net Income	-$31.3M-32.9%	-$23.5M+7.2%	-$25.4M+45.9%	-$46.9M-103.0%	-$23.1M+87.2%	-$180.0M-623.3%	-$24.9M-6.2%	-$23.4M
EPS (Diluted)	N/A	$-0.44+27.9%	$-0.61+54.5%	$-1.34	N/A	$-7.63-569.3%	$-1.14-1.8%	$-1.12

CBUS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$305.0M-12.9%	$350.1M-35.7%	$544.4M+2328.1%	$22.4M-39.7%	$37.2M-41.3%	$63.3M
Current Assets	$12.1M-28.8%	$16.9M-51.9%	$35.2M+752.4%	$4.1M-72.8%	$15.2M-61.7%	$39.6M
Cash & Equivalents	$9.9M-31.2%	$14.4M-55.9%	$32.7M+854.2%	$3.4M-75.2%	$13.8M-20.1%	$17.3M
Inventory	N/A	N/A	N/A	N/A	$0-100.0%	$1.4M
Accounts Receivable	$503K-51.7%	$1.0M+96.4%	$530K	$0	$0-100.0%	$4.9M
Goodwill	$232.5M-8.3%	$253.5M-41.7%	$434.9M	$0	N/A	N/A
Total Liabilities	$283.2M+12.3%	$252.2M+22.4%	$206.1M+1257.1%	$15.2M-34.1%	$23.1M-12.8%	$26.5M
Current Liabilities	$16.9M-15.2%	$19.9M-6.8%	$21.3M+1183.0%	$1.7M-65.8%	$4.9M-30.1%	$6.9M
Long-Term Debt	$93K-58.8%	$226K-57.8%	$536K	$0	$0-100.0%	$1.5M
Total Equity	$21.8M-76.3%	$92.2M-68.6%	$293.5M+3957.4%	$7.2M-48.8%	$14.1M-61.7%	$36.9M
Retained Earnings	-$858.3M-17.4%	-$731.2M-52.4%	-$479.8M-126.1%	-$212.2M-8.2%	-$196.1M-17.5%	-$166.9M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$305.0M-7.6%	$330.2M-4.6%	$346.2M+3.3%	$335.0M-4.3%	$350.1M-4.8%	$367.9M-33.5%	$553.4M+3.8%	$533.0M
Current Assets	$12.1M-54.0%	$26.2M-34.1%	$39.8M+53.9%	$25.9M+52.7%	$16.9M-46.3%	$31.6M-4.6%	$33.1M+23.9%	$26.7M
Cash & Equivalents	$9.9M-58.5%	$23.9M-34.5%	$36.5M+54.6%	$23.6M+63.4%	$14.4M-49.9%	$28.8M-4.1%	$30.0M+22.5%	$24.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$503K-16.7%	$604K-36.6%	$953K+0.3%	$950K-8.7%	$1.0M-12.5%	$1.2M+12.5%	$1.1M+62.8%	$650K
Goodwill	$232.5M0.0%	$232.5M0.0%	$232.5M0.0%	$232.5M-8.3%	$253.5M0.0%	$253.5M-41.7%	$434.9M0.0%	$434.9M
Total Liabilities	$283.2M+1.8%	$278.2M+2.4%	$271.7M+4.1%	$261.1M+3.5%	$252.2M+2.1%	$247.0M+0.3%	$246.3M+15.5%	$213.2M
Current Liabilities	$16.9M-18.0%	$20.6M-8.3%	$22.4M+6.7%	$21.0M+5.7%	$19.9M-9.3%	$21.9M-24.3%	$29.0M+33.4%	$21.7M
Long-Term Debt	$93K-19.8%	$116K-17.1%	$140K-22.2%	$180K-20.4%	$226K-22.3%	$291K-20.3%	$365K-17.2%	$441K
Total Equity	$21.8M-56.7%	$50.4M-30.1%	$72.1M+2.6%	$70.3M-23.7%	$92.2M-14.8%	$108.1M-60.0%	$270.5M-2.8%	$278.2M
Retained Earnings	-$858.3M-3.8%	-$827.0M-2.9%	-$803.4M-3.3%	-$778.1M-6.4%	-$731.2M-3.3%	-$708.1M-34.1%	-$528.1M-4.9%	-$503.2M

CBUS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$50.6M+12.8%	-$58.0M-25.6%	-$46.2M-138.6%	-$19.4M-2.9%	-$18.8M+56.9%	-$43.7M
Capital Expenditures	$578K-28.5%	$808K-81.3%	$4.3M+184.3%	$1.5M+205.8%	$497K-72.2%	$1.8M
Free Cash Flow	-$51.2M+13.1%	-$58.9M-16.5%	-$50.5M-142.0%	-$20.9M-8.2%	-$19.3M+57.5%	-$45.5M
Investing Cash Flow	-$578K+28.5%	-$808K-101.5%	$55.1M+3722.4%	-$1.5M-113.6%	$11.2M+183.1%	-$13.5M
Financing Cash Flow	$46.6M+14.9%	$40.6M+99.8%	$20.3M+103.4%	$10.0M+166.9%	$3.7M-75.7%	$15.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$13.4M-14.3%	-$11.7M+13.7%	-$13.6M-15.0%	-$11.8M+15.5%	-$14.0M-3.5%	-$13.5M+20.7%	-$17.0M-26.5%	-$13.5M
Capital Expenditures	$86K-20.4%	$108K+16.1%	$93K-68.0%	$291K+419.6%	$56K-84.2%	$355K+110.1%	$169K-25.9%	$228K
Free Cash Flow	-$13.5M-14.0%	-$11.8M+13.5%	-$13.7M-13.0%	-$12.1M+13.8%	-$14.1M-1.3%	-$13.9M+19.4%	-$17.2M-25.6%	-$13.7M
Investing Cash Flow	-$86K+20.4%	-$108K-16.1%	-$93K+68.0%	-$291K-419.6%	-$56K+84.2%	-$355K-110.1%	-$169K+25.9%	-$228K
Financing Cash Flow	-$458K+36.8%	-$725K-102.7%	$26.6M+24.9%	$21.3M+7050.7%	-$306K-102.4%	$12.7M-44.3%	$22.7M+311.9%	$5.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CBUS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	100.0%+109.9pp	-9.9%+37.4pp	-47.3%
Operating Margin	-2680.1%+3382.7pp	-6062.8%+11487.2pp	-17550.0%-3301.6pp	-14248.4%-14135.5pp	-112.9%+70.9pp	-183.8%
Net Margin	-3492.3%+2406.1pp	-5898.4%+8830.7pp	-14729.1%-3970.5pp	-10758.6%-10646.2pp	-112.4%+75.6pp	-188.0%
Return on Equity	-582.2%-309.4pp	-272.8%-181.6pp	-91.2%+142.3pp	-233.5%-26.9pp	-206.6%-85.0pp	-121.6%
Return on Assets	-41.7%+30.1pp	-71.8%-22.6pp	-49.2%+26.2pp	-75.3%+3.2pp	-78.5%-7.7pp	-70.8%
Current Ratio	0.72-0.1	0.85-0.8	1.65-0.8	2.49-0.6	3.13-2.6	5.70
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	0.00-0.0	0.04
FCF Margin	-1406.1%-25.3pp	-1380.8%+1400.2pp	-2781.0%+10520.9pp	-13301.9%-13227.6pp	-74.3%+116.3pp	-190.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-2135.7%+374.6pp	-2510.2%-586.8pp	-1923.5%+2096.9pp	-4020.4%-2533.3pp	-1487.1%+10536.7pp	-12023.8%-9460.3pp	-2563.5%+822.4pp	-3385.9%
Net Margin	-2959.9%+867.9pp	-3827.8%-1108.4pp	-2719.4%+1815.0pp	-4534.4%-2628.3pp	-1906.1%+8889.8pp	-10795.9%-7826.6pp	-2969.3%+1330.7pp	-4300.0%
Return on Equity	-143.3%-96.6pp	-46.7%-11.5pp	-35.2%+31.5pp	-66.7%-41.7pp	-25.1%+141.3pp	-166.4%-157.2pp	-9.2%-0.8pp	-8.4%
Return on Assets	-10.3%-3.1pp	-7.1%+0.2pp	-7.3%+6.7pp	-14.0%-7.4pp	-6.6%+42.3pp	-48.9%-44.4pp	-4.5%-0.1pp	-4.4%
Current Ratio	0.72-0.6	1.28-0.5	1.78+0.5	1.23+0.4	0.85-0.6	1.44+0.3	1.14-0.1	1.23
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.00
FCF Margin	-1277.8%+648.7pp	-1926.5%-458.4pp	-1468.1%-296.1pp	-1172.0%-12.6pp	-1159.3%-327.0pp	-832.3%+1222.2pp	-2054.5%+460.7pp	-2515.2%

Note: The current ratio is below 1.0 (0.72), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

CEL-SCI Corp CVM

$29.3M

Igm Biosciences, Inc. IGMS

$76.6M

Adicet Bio Inc ACET

$67.1M

Vivani Medical VANI

$91.4M

Repare Therapeutics Inc. RPTX

$114.2M

Frequently Asked Questions

What is CIBUS INC's annual revenue?

CIBUS INC (CBUS) reported $3.6M in total revenue for fiscal year 2025. This represents a -14.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CIBUS INC's revenue growing?

CIBUS INC (CBUS) revenue declined by 14.6% year-over-year, from $4.3M to $3.6M in fiscal year 2025.

Is CIBUS INC profitable?

No, CIBUS INC (CBUS) reported a net income of -$127.1M in fiscal year 2025, with a net profit margin of -3492.3%.

What is CIBUS INC's EBITDA?

CIBUS INC (CBUS) had EBITDA of -$91.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CIBUS INC have?

As of fiscal year 2025, CIBUS INC (CBUS) had $9.9M in cash and equivalents against $93K in long-term debt.

What is CIBUS INC's operating margin?

CIBUS INC (CBUS) had an operating margin of -2680.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CIBUS INC's net profit margin?

CIBUS INC (CBUS) had a net profit margin of -3492.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CIBUS INC's return on equity (ROE)?

CIBUS INC (CBUS) has a return on equity of -582.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CIBUS INC's free cash flow?

CIBUS INC (CBUS) generated -$51.2M in free cash flow during fiscal year 2025. This represents a 13.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CIBUS INC's operating cash flow?

CIBUS INC (CBUS) generated -$50.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CIBUS INC's total assets?

CIBUS INC (CBUS) had $305.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CIBUS INC's capital expenditures?

CIBUS INC (CBUS) invested $578K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does CIBUS INC spend on research and development?

CIBUS INC (CBUS) invested $44.2M in research and development during fiscal year 2025.

What is CIBUS INC's current ratio?

CIBUS INC (CBUS) had a current ratio of 0.72 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is CIBUS INC's debt-to-equity ratio?

CIBUS INC (CBUS) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CIBUS INC's return on assets (ROA)?

CIBUS INC (CBUS) had a return on assets of -41.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CIBUS INC's cash runway?

Based on fiscal year 2025 data, CIBUS INC (CBUS) had $9.9M in cash against an annual operating cash burn of $50.6M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is CIBUS INC's Piotroski F-Score?

CIBUS INC (CBUS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CIBUS INC's earnings high quality?

CIBUS INC (CBUS) has an earnings quality ratio of 0.40x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is CIBUS INC?

CIBUS INC (CBUS) scores 20 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.